We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$368M
AUM Growth
+$240M
Cap. Flow
+$255M
Cap. Flow %
69.4%
Top 10 Hldgs %
25.49%
Holding
710
New
414
Increased
42
Reduced
13
Closed
237

Top Buys

Rank Stock Value
1
VABS icon
Virtus Newfleet ABS/MBS ETF
VABS
+$32.2M
2
VSHY icon
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
+$24.8M
3
SEIX icon
Virtus SEIX Senior Loan ETF
SEIX
+$19.2M
4
SMC
Summit Midstream
SMC
+$4.35M
5
OCCI
OFS Credit Co
OCCI
+$2.75M

Top Sells

Rank Stock Value
1
IBN icon
ICICI Bank
IBN
+$3.75M
2
VCLN icon
Virtus Duff & Phelps Clean Energy ETF
VCLN
+$2.74M
3
AAPL icon
Apple
AAPL
+$2.06M
4
MSFT icon
Microsoft
MSFT
+$2.02M
5
PRIM icon
Primoris Services
PRIM
+$1.86M

Sector Composition

Rank Sector Weight
1 Financials 24.48%
2 Healthcare 11.95%
3 Technology 8.6%
4 Industrials 8.02%
5 Energy 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
226
Acadia Pharmaceuticals
ACAD
$5.06B
$346K 0.09%
20,804
-18,566
-47% -$337K
BPMC
227
DELISTED
Blueprint Medicines
BPMC
$343K 0.09%
+3,878
New +$378K
LEGN icon
228
Legend Biotech
LEGN
$4.04B
$343K 0.09%
+10,116
New +$363K
RYTM icon
229
Rhythm Pharmaceuticals
RYTM
$7.94B
$341K 0.09%
+6,446
New +$358K
NCDL icon
230
Nuveen Churchill Direct Lending
NCDL
$613M
$340K 0.09%
+20,015
New +$344K
ARDX icon
231
Ardelyx
ARDX
$992M
$336K 0.09%
+68,515
New +$368K
LGND icon
232
Ligand Pharmaceuticals
LGND
$6.27B
$332K 0.09%
+3,162
New +$358K
TBPH icon
233
Theravance Biopharma
TBPH
$875M
$325K 0.09%
+36,379
New +$339K
BIIB icon
234
Biogen
BIIB
$30.7B
$316K 0.09%
+2,311
New +$330K
NBIX icon
235
Neurocrine Biosciences
NBIX
$16.7B
$313K 0.09%
2,833
-1,152
-29% -$146K
REGN icon
236
Regeneron Pharmaceuticals
REGN
$82.6B
$308K 0.08%
+486
New +$334K
UTHR icon
237
United Therapeutics
UTHR
$22.6B
$306K 0.08%
+994
New +$341K
ROIV icon
238
Roivant Sciences
ROIV
$25.9B
$305K 0.08%
+30,219
New +$327K
AUPH icon
239
Aurinia Pharmaceuticals
AUPH
$2.06B
$298K 0.08%
37,051
-45,777
-55% -$371K
IONS icon
240
Ionis Pharmaceuticals
IONS
$9.53B
$293K 0.08%
+9,701
New +$318K
FOLD
241
DELISTED
Amicus Therapeutics
FOLD
$289K 0.08%
35,370
+20,270
+134% +$188K
PHAT icon
242
Phathom Pharmaceuticals
PHAT
$687M
$282K 0.08%
+44,964
New +$273K
RARE icon
243
Ultragenyx Pharmaceutical
RARE
$2.56B
$277K 0.08%
+7,655
New +$318K
AGIO icon
244
Agios Pharmaceuticals
AGIO
$1.93B
$276K 0.07%
+9,408
New +$312K
BNTX icon
245
BioNTech
BNTX
$23.5B
$271K 0.07%
+2,976
New +$333K
CRSP icon
246
CRISPR Therapeutics
CRSP
$5.2B
$269K 0.07%
+7,905
New +$335K
XERS icon
247
Xeris Biopharma Holdings
XERS
$1.47B
$265K 0.07%
+48,288
New +$195K
NVAX icon
248
Novavax
NVAX
$1.3B
$255K 0.07%
+39,805
New +$329K
SLNO
249
DELISTED
Soleno Therapeutics
SLNO
$253K 0.07%
+3,543
New +$173K
APLS
250
DELISTED
Apellis Pharmaceuticals
APLS
$240K 0.07%
+10,967
New +$303K
8 9
10
11 12

Similar funds

MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return
SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
RGC
Roberts, Glore & Co Deerfield, Illinois $364M AUM 19.54% 1-Year Est. Return

Virtus Investment Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Virtus Investment Advisers held 710 positions worth $368M, up 188% from $128M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Virtus Investment Advisers deployed $255M of net new capital in Q1 2025, opening 414 new positions and adding to 42 existing holdings. Its largest new stake was Virtus Newfleet ABS/MBS ETF: 1,321,000 shares worth $32.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Berry Corp, an estimated $666K trimmed.

  • Virtus Investment Advisers's largest Q1 2025 buy was Virtus Newfleet ABS/MBS ETF: 1,321,000 shares worth $32.2M.
  • Virtus Investment Advisers added most to Yum China in Q1 2025, an estimated $1.42M increase.
  • Virtus Investment Advisers's biggest Q1 2025 reduction was Berry Corp, cutting an estimated $666K.
  • Virtus Investment Advisers fully exited ICICI Bank in Q1 2025, selling an estimated $3.75M.
  • Virtus Investment Advisers's ten largest holdings make up 25% of its $368M portfolio in Q1 2025.
  • Virtus Investment Advisers opened 414 new positions and closed 237 in Q1 2025.
  • Virtus Investment Advisers's portfolio value rose 188% quarter-over-quarter to $368M.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.